Lactic acidosis.

Hyperlactatemia in a group of HIV patients living in Yaounde-Cameroon. AIDS Res Ther (2014) 0.82

Liver specific expression of Cu/ZnSOD extends the lifespan of Sod1 null mice. Mech Ageing Dev (2016) 0.75

Evaluation of oxidative stress markers for the early diagnosis of allograft rejection in feline renal allotransplant recipients with normal renal function. Can Vet J (2004) 0.75

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46

The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36

Haemorrhagic fever with renal syndrome, 1993: endemic or unrecognised pandemic? Lancet (1993) 3.77

The nephrotic syndrome. N Engl J Med (1998) 3.22

Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98

Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42

Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38

The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06

Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98

Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83

Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77

Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71

Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61

Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59

Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54

Alcohol abuse: potential role in electrolyte disturbances and kidney diseases. Clin Nephrol (1998) 1.54

Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49

In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49

Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48

Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48

Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43

Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42

Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42

The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41

Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41

[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40

Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40

[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39

Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39

[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39

Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39

Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38

Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38

Dialysis membranes inhibit in vitro release of beta-2-microglobulin from human lymphocytes. Nephron (1990) 1.38

Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38

Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38

Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38

[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38

Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol (1998) 1.37

The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant (1998) 1.36

Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35

Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34

Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int (1999) 1.33

Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32

Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32

Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant (1992) 1.30

Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30

1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28

Cancer in end-stage renal disease: potential factors involved -editorial-. Am J Nephrol (1998) 1.28

Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. Kidney Int (1988) 1.27

Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int (1997) 1.27

Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26

Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int (1987) 1.24

Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol (1993) 1.24

Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24

Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol (1991) 1.23

Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22

Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA. Eur J Clin Chem Clin Biochem (1997) 1.21

Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med (1979) 1.21

Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet (1991) 1.20

Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20

Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant (1998) 1.19

Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int (1973) 1.18

Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol (1988) 1.17

Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant (1989) 1.17

A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol (1994) 1.17

1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int (1989) 1.16

Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia (2003) 1.14

Coadministration of albumin and furosemide in patients with the nephrotic syndrome. Kidney Int (1999) 1.14

Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids. Exp Cell Res (1973) 1.14

Ototoxic side-effects of high doses of frusemide in patients with uraemia. Postgrad Med J (1971) 1.12

Reduced capillary density in the myocardium of uremic rats--a stereological study. Kidney Int (1992) 1.12

Beta blockers in the management of chronic kidney disease. Kidney Int (2006) 1.11

Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1993) 1.11

Demonstration of 1,25(OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int (1987) 1.11

No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest (1997) 1.10

The renal risks of smoking. Kidney Int (1997) 1.10

Similar risks of nephropathy in patients with type I or type II diabetes mellitus. Nephrol Dial Transplant (1989) 1.10

Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine. J Am Soc Nephrol (1996) 1.10

Association of ACE gene polymorphism and diabetic nephropathy? The Diabetic Nephropathy Study Group. Kidney Int (1995) 1.09

Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol (2000) 1.09

Podocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides. Kidney Int (1997) 1.08

Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function. J Lab Clin Med (1992) 1.08

Renal function: the Cinderella of cardiovascular risk profile. J Am Coll Cardiol (2001) 1.08

Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant (2000) 1.07

Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis (1989) 1.07

Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritis. J Am Soc Nephrol (2001) 1.06

Genetic polymorphism of C3 and Bf in IgA nephropathy. Nephrol Dial Transplant (1987) 1.05

Blood pressure and metabolic control as risk factors for nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia (1985) 1.05

Inhibition of Na+,K+-stimulated ATPase in the cochlea of the guinea pig. A potential cause of disturbed inner ear function in terminal renal failure. Acta Otolaryngol (1980) 1.04

Renal function in the elderly--is the dogma of an inexorable decline of renal function correct? Nephrol Dial Transplant (1997) 1.04

Fluid phase generation of terminal complement complex as a novel index of bioincompatibility. Kidney Int (1990) 1.03

[Possibilities and limitations of high dosage diuretic therapy in hydropic renal insufficiency]. Dtsch Med Wochenschr (1969) 1.03

Special characteristics of atherosclerosis in chronic renal failure. Clin Nephrol (2003) 1.03

Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int (1994) 1.03

Expression of receptors for advanced glycosylated end-products in renal disease. Nephrol Dial Transplant (1995) 1.02